Brian D. Frenzel
12Patents
3h-index
7Co-inventors
49Inventor score
Filing activity: Feb 11, 2009 → Jul 7, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7998967B2 | Methotrexate adjuvants to reduce toxicity and methods for using the same | Human Necessities | 7 | Active |
| US8853227B2 | Methotrexate adjuvants to reduce toxicity and methods for using the same | Human Necessities | 6 | Active |
| US9061038B2 | Doxorubicin adjuvants to reduce toxicity and methods for using the same | Human Necessities | 5 | Active |
| USRE48253E1 | Methotrexate adjuvants to reduce toxicity and methods for using the same | General | 3 | Active |
| US9382287B2 | Methotrexate adjuvants to reduce toxicity and methods for using the same | Human Necessities | 3 | Active |
| US11446303B2 | Uridine phosphorylase (UPase) inhibitors for treatment of liver conditions | Human Necessities | 1 | Active |
| US12109222B2 | Methods and compositions for treating mucositis | Human Necessities | 0 | Active |
| US11945803B2 | Modulators of RAS GTPase | Chemistry; Metallurgy | 0 | Active |
| US8227517B2 | Doxorubicin adjuvants to reduce toxicity and methods for using the same | Human Necessities | 0 | Active |
| US12419893B2 | Methods and compositions for maximizing the prevention and/or reduction of various maladies and drug side-effects using uridine | Human Necessities | 0 | Active |
| US12194043B2 | Uridine phosphorylase inhibitors to treat or prevent pulmonary disease | Human Necessities | 0 | Active |
| US9468613B2 | Doxorubicin adjuvants to reduce toxicity and methods for using the same | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.